NIAID provides grant for AIDS vaccine research in nonhuman primates

The Beth Israel Deaconess Medical Center recently received a grant from the National Institute of Allergy and Infectious Diseases to lead a consortium for AIDS vaccine research in nonhuman primates.

NIAID, which is part of the U.S. National Institutes of Health, awarded BIDMC a five year grant totaling $36 million.

BIDMC Chief of Vaccine Research Dr. Dan Barouch will co-head the consortium with Dr. R. Paul Johnson from the New England Primate Research Center. Both Barouch and Johnson are also professors at Harvard Medical School. Barouch’s laboratory focuses on the virology and immunology of the HIV-1 infection and the development of novel vaccine strategies.

“The goal of the consortium is to elucidate the earliest immunologic and pathologic events at mucosal surfaces following virus infection, and to determine the ability of multiple leading vaccine candidates to block or to attenuate these events,” Barouch said.

BIDMC’s Division of Vaccine Research is a part of the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery, the NIAID-funded Center for HIV/AIDS Vaccine Immunology and the Ragon Institute.

The NIAID recently awarded a five year $26 million grant to HIV/AIDS vaccine researchers at Emory University in Atlanta. The fund will create the Emory Consortium for AIDS Vaccine Research in Nonhuman Primates.

Organizations in this Story

National Institutes of Health

Want to get notified whenever we write about National Institutes of Health ?
Next time we write about National Institutes of Health, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.